Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Clinigen Group PLC: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

30 Jan 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Clinigen Group PLC (CLIN-LN)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

05 Feb 2016 Thomson Reuters Stock Report 11 $25.00

Wright Investors Service Comprehensive Report for Clinigen Group PLC

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

05 Feb 2016 Wright Reports 54 $75.00

CLINIGEN GROUP - H1 TRADING IN LINE, WITH H2 ACCELERATION IN SIGHT

Clinigen’s H116 trading statement suggests its business is performing to plan, taking into account some revenue deferrals to ...

25 Jan 2016 Edison Investment Research 3 $10.00

Clinigen Group PLC: Upgraded to Average

25 Jan 2016 Sadif Analytics Prime 3 $10.00

Clinigen Group Plc (CLIN) - Financial Analysis Review

Clinigen Group Plc (CLIN) - Financial Analysis Review Summary Clinigen Group plc (Clinigen Group) is a specialty pharmaceutic...

21 Jan 2016 GlobalData 49 $300.00

Peel Hunt: Clinigen (Buy) - Building a global leader

Peel Hunt: Clinigen (Buy) - Building a global leader

19 Jan 2016 Peel Hunt 4 $23.00

Clinigen Group Plc (CLIN) - Financial Analysis Review

Clinigen Group Plc (CLIN) - Financial Analysis Review Summary Clinigen Group plc (Clinigen Group) is a specialty pharmaceutic...

11 Dec 2015 GlobalData 52 $300.00

CLINIGEN GROUP - EXPANSION STRATEGY SET TO ACCELERATE EARNINGS

Clinigen’s FY15 results demonstrated strong underlying fundamentals, with earnings and net debt better than our forecasts. Th...

13 Oct 2015 Edison Investment Research 8 $10.00

Company Snapshot - Clinigen Group

Four Directors at Clinigen Group sold after exercising options/sold 2,329,798 shares at 685p. The significance rating of the ...

07 Oct 2015 Directors Deals Ltd. 1 $12.00